Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 7/20 | 0.41 |
| ▸ | REN | P00797 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PEPD | P12955 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13555216 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2RAB9AACERENLMNA | |
| SCHEMBL4555126 | 0.84 | SPHK1 (0.40) | SMN1; SMN2RAB9ALMNAKDM4E | |
| SCHEMBL18555352 | 0.84 | SPHK1 (0.40) | SMN1; SMN2RAB9ALMNAKDM4E | |
| SCHEMBL4959163 | 0.82 | LTA4H (0.45) | SMN1; SMN2RAB9AACELTA4HSLC6A1 | |
| SCHEMBL4959171 | 0.82 | LTA4H (0.45) | SMN1; SMN2RAB9AACELTA4HSLC6A1 | |
| SCHEMBL6568062 | 0.82 | LTA4H (0.45) | SMN1; SMN2RAB9AACELTA4HSLC6A1 | |
| SCHEMBL17416357 | 0.81 | HSD17B10 (0.45) | SMN1; SMN2RAB9AACERENLMNA | |
| SCHEMBL6523272 | 0.80 | SMN1; SMN2 (0.40) | SMN1; SMN2LMNAHSD17B10CYP2C19 | |
| SCHEMBL16418017 | 0.80 | SMN1; SMN2 (0.43) | SMN1; SMN2RAB9AACERENLMNA | |
| SCHEMBL8283493 | 0.79 | SMN1; SMN2 (0.45) | SMN1; SMN2RAB9AACERENLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183405-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| EP-2852587-A1 | ANTIVIRAL COMPOUNDS WITH AN IMIDAZOLE - BIPHENYL - IMIDAZOLE CORE | Gilead Sciences, Inc. (US) | 2015-04-01 | — | — | EP | disclosed |
| WO-2013173492-A1 | ANTIVIRAL COMPOUNDS WITH AN IMIDAZOLE - BIPHENYL - IMIDAZOLE CORE | GILEAD SCIENCES, INC. (US) | 2013-11-21 | — | — | WO | disclosed |
| EP-2640719-A2 | ANTIVIRAL COMPOUNDS | Gilead Sciences, Inc. (US) | 2013-09-25 | — | — | EP | disclosed |
| EP-2509971-A1 | NEW PROCESS FOR THE PREPARATION OF DRONEDARONE | SANOFI (FR) | 2012-10-17 | — | — | EP | disclosed |
| WO-2012068234-A2 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2011073376-A1 | PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERSAS AS AGONISTS OF G- PROTEIN COUPLED RECEPTOR 43 (GPR43) | EUROSCREEN S.A. (BE) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011070380-A1 | NEW PROCESS FOR THE PREPARATION OF DRONEDARONE | SANOFI-AVENTIS (FR) | 2011-06-16 | — | — | WO | disclosed |